Claire Fraser - Jun 22, 2023 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Stock symbol
MCRB
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 05:25 PM
Previous filing
Jan 26, 2023
Next filing
Aug 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +35K $0.00 35K Jun 22, 2023 Common Stock 35K $5.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders.